S56 Hormones in Metabolic Adaptations

Program: Symposia
Translational Session
Sunday, April 3, 2016: 4:45 PM-6:15 PM
Room 205 (BCEC)
Chair:
James Ernest Blevins, PhD, VA Puget Sound Health Care System, Seattle, WA

Nothing to Disclose: JEB
4:45 PM
Gareth Leng, PhD, Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
Nothing to Disclose: GL
5:15 PM
Jose Donato Jr., PhD, Department of Physiology and Biophysics, University of Sao Paulo, Sao Paulo - SP, Brazil
Nothing to Disclose: JD Jr.
5:45 PM
Elizabeth A. Lawson, MD, MMSc, Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA
Nothing to Disclose: EAL
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire